Abstract:Background: Protein theranostics integrate both diagnostic and treatment functions on a single disease-targeting protein. However, the preparation of these multimodal agents remains a major challenge. Ideally, conventional recombinant proteins should be used as starting materials for modification with the desired detection and therapeutic functionalities, but simple chemical strategies that allow the introduction of two different modifications into a protein in a site-specific manner are not currently available. We recently discovered two highly efficient peptide ligases, namely butelase-1 and VyPAL2. Although both ligate at asparaginyl peptide bonds, these two enzymes are bio-orthogonal with distinguishable substrate specificities, which can be exploited to introduce distinct modifications onto a protein.Methods: We quantified substrate specificity differences between butelase-1 and VyPAL2, which provide orthogonality for a tandem ligation method for protein dual modifications. Recombinant proteins or synthetic peptides engineered with the preferred recognition motifs of butelase-1 and VyPAL2 at their respective C- and N-terminal ends could be modified consecutively by the action of the two ligases.Results: Using this method, we modified an EGFR-targeting affibody with a fluorescein tag and a mitochondrion-lytic peptide at its respective N- and C-terminal ends. The dual-labeled protein was found to be a selective bioimaging and cytotoxic agent for EGFR-positive A431 cancer cells. In addition, the method was used to prepare a cyclic form of the affibody conjugated with doxorubicin. Both modified affibodies showed increased cytotoxicity to A431 cells by 10- and 100-fold compared to unconjugated doxorubicin and the free peptide, respectively.Conclusion: Bio-orthogonal tandem ligation using two asparaginyl peptide ligases with differential substrate specificities is a straightforward approach for the preparation of multifunctional protein biologics as potential theranostics.

Site-specific protein modification using lipoic acid ligase and bis-aryl hydrazone formation.

Investigation of Protein Post-Translational Modifications with Site-Specifically Incorporated Non-Canonical Amino Acids

Ligand-free Palladium-Mediated Site-Specific Protein Labeling Inside Gram-Negative Bacterial Pathogens.

Ligand-assisted Dual-Site Click Labeling of EGFR on Living Cells.

Directed evolution of a probe ligase with activity in the secretory pathway and application to imaging intercellular protein-protein interactions

Fluorophore Targeting to Cellular Proteins via Enzyme-Mediated Azide Ligation and Strain-Promoted Cycloaddition

Tag-Free Protein Modification by Lipoate Ligase A: Exploring Substrate Tolerance

Lysine acylation using conjugating enzymes for site-specific modification and ubiquitination of recombinant proteins

Thiol-yne Radical Reaction Mediated Site-Specific Protein Labeling Via Genetic Incorporation of an Alkynyl-L-lysine Analogue.

Efficient Enzymatic Incorporation of Dehydroalanine Based on SAMDI-Assisted Identification of Optimized Tags for OspF/SpvC

Site‐Specific Anchoring a Luminescent Tag in a Protein with Non‐Emissive Iridium(III) Complex

Computational design of a red fluorophore ligase for site-specific protein labeling in living cells

Rapid, Stoichiometric, Site-Specific Modification of Aldehyde-Containing Proteins Using a Tandem Knoevenagel-Intra Michael Addition Reaction.

Late-stage C(sp2)-H and C(sp3)-H Glycosylation Ofc-Aryl/alkyl Glycopeptides: Mechanistic Insights and Fluorescence Labeling

Analyzing protein posttranslational modifications using enzyme-catalyzed expressed protein ligation

Cleavable Cys labeling directed Lys site-selective stapling and single-site modification

Analytical studies on the conjugation site specificity of trastuzumab modified by Escherichia coli lipoate ligase A: multiple-enzyme digestion approach for peptide mapping

Genetically Encoded Alkenyl-Pyrrolysine Analogues For Thiol-Ene Reaction Mediated Site-Specific Protein Labeling

Thioester-Assisted Sortase-A-Mediated Ligation.

Engineering protein theranostics using bio-orthogonal asparaginyl peptide ligases